Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Viral DNA synthesis via host factor modulation refers to the process by which viruses manipulate host cellular proteins and pathways to facilitate the replication of their own DNA genomes. Viruses, being obligate intracellular parasites, rely on hijacking or modulating host factors to create a favorable environment for viral genome synthesis. This involves recruiting proviral host dependency factors (HDFs) and evading or inactivating host restriction factors (HRFs). Targeting these virus-host interactions is an emerging therapeutic strategy known as host-directed therapy, however, only those host targets whose inhibition does not severely disrupt normal cell function are considered viable drug targets.
Inhibition of proviral HDFs; Enhancement or mimicking of HRF activity
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral DNA Synthesis via Host Factor Modulation.